News | Neuro Imaging | August 26, 2016

Brain Activity, Response to Food Cues Differ in Severely Obese Women

MRI scans reveal interest in food based on brain activity declined only marginally in obese women compared to lean women, even after a full meal

brain activity, obese women, food cues, UT Southwestern study

August 26, 2016 — The brain’s reward centers in severely obese women continue to respond to food cues even after they’ve eaten and are no longer hungry, in contrast to their lean counterparts, according to a recent study. The study was conducted by a multidisciplinary team at University of Texas (UT) Southwestern Medical Center.

The study, published recently in the journal Obesity, compared attitudes and the brain activity of 15 severely obese women (those with a body mass index greater than 35) and 15 lean women (those with a BMI under 25).

Magnetic resonance imaging (MRI) scans of the study participants were taken before and after a meal. Both groups showed significantly increased activity in the neo- and limbic cortices and midbrain when they were hungry. After eating, however, that brain activity dropped among lean participants while continuing in their obese counterparts.

Even after eating and reporting they were full, the severely obese women continued to react to pictures of food in much the same way they had when fasting, as exhibited in brain scans.

“Before or after the meal, they’re just as excited about eating,” said Nancy Puzziferri, M.D., assistant professor of surgery at UT Southwestern and senior author of the study. “It seems they have an instinctive drive to keep eating.”

While the appeal of pictured food dropped 15 percent for the lean women after they ate, the severely obese women showed only a 4 percent decline, based on brain scans using functional magnetic resonance imaging (fMRI) to measure brain activity. After eating, activity in regions in the prefrontal cortex and posterior cingulate cortex significantly changed in the lean group, but not in the obese group. The obese study participants maintained activation in the midbrain, one of the body’s most potent reward centers.

Study participants had fasted for nine hours prior to testing. They were asked to rate their level of hunger or fullness, then given a brain scan as they viewed pictures of food. Again, they were asked to rate their level of hunger. Over the next hour, the women were fed a meal of lean beef or chicken, potatoes or rice, green beans, canned peaches, and iced tea or water. After eating, the participants went through another battery of hunger/fullness ratings and fMRI scans while exposed to pictures of food.   

The obese women showed sustained “hungry” brain activation, even though they reported the same increase in satiation as their lean counterparts.

“These findings may explain why some people with severe obesity report an underlying drive to eat continually despite not feeling hungry,” said Puzziferri, who specializes in bariatric and weight loss surgery. “In contrast, lean women when full will either stop eating or just sample a food they crave. It’s just not a level playing field — it’s harder for some people to maintain a healthy weight than others.”

The severely obese women in the study, who weighed between 202 and 316 pounds, were candidates for bariatric surgery to lose weight. The study is following these women after surgery to determine if their brain activation patterns change.

The study was conducted at UT Southwestern and VA North Texas Health Care System. Funding for the research came from UT Southwestern and the National Institutes of Health.

Study co-authors from UT Southwestern include Thomas Carmody, Ph.D., associate professor of clinical science and psychiatry; Carol Tamminga, M.D., chair of psychiatry, and holder of the Lou and Ellen McGinley Distinguished Chair in Psychiatric Research, and the Communities Foundation of Texas Inc. Chair in Brain Science; and Jeffrey Zigman, M.D., Ph.D., associate professor of internal medicine and psychiatry, and holder of The Diana and Richard C. Strauss Professorship in Biomedical Research and the Mr. and Mrs. Bruce G. Brookshire Professorship in Medicine.

For more information: www.obesity.org/publications/obesity-journal

Related Content

Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Medtronic Recalls Synergy Cranial Software and Stealth Station S7 Cranial Software
News | Procedure Navigation Systems | February 05, 2019
Medtronic is recalling the Synergy Cranial Software and StealthStation S7 Cranial Software used with the StealthStation...
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...